Heterocyclic Anticancer Agents

Buch | Hardcover
XX, 512 Seiten
2022
De Gruyter (Verlag)
978-3-11-073926-8 (ISBN)
230,00 inkl. MwSt
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.

lt;p>Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.

Erscheinungsdatum
Zusatzinfo 50 b/w and 100 col. ill., 50 b/w and 15 col. tbl.
Verlagsort Berlin/Boston
Sprache englisch
Maße 170 x 240 mm
Gewicht 1017 g
Themenwelt Naturwissenschaften Chemie Technische Chemie
Technik
Schlagworte Anticancer agents • Heterocycles • Krebsbekämpfung • Organic Chemistry • Organische Chemie • Pharmaceutical Chemistry. • Pharmazeutische Chemie
ISBN-10 3-11-073926-7 / 3110739267
ISBN-13 978-3-11-073926-8 / 9783110739268
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Manfred Baerns; Arno Behr; Axel Brehm; Jürgen Gmehling …

Buch | Hardcover (2023)
Wiley-VCH (Verlag)
94,90
erneuerbare Energien und Speichertechnologien für die Energiewende

von Jürgen Karl

Buch | Softcover (2023)
De Gruyter Oldenbourg (Verlag)
64,95
Alles zu Messunsicherheit, konventioneller Messtechnik und …

von Michael Marxer; Carlo Bach; Claus P. Keferstein

Buch | Softcover (2021)
Springer Vieweg (Verlag)
37,99